FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine | .032 mg/1 mL | 2023-2 | valid | 2026-10-13 | ||
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine | .032 mg/1 mL | 2023-1 | valid | 2026-10-13 | ||
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine | .032 mg/1 mL | 2022-1 | valid | 2026-10-13 | ||
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine; Sodium Chloride; Sodium Metabisulfite | .032 mg/1 mL; .2638 mg/1 mL; .064 mg/1 mL | 2021-2 | valid | 2026-10-13 | ||
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine; Sodium Chloride; Sodium Metabisulfite | .032 mg/1 mL; .2638 mg/1 mL; .064 mg/1 mL | 2021-1 | valid | 2026-10-13 | ||
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine; Sodium Chloride; Sodium Metabisulfite | .032 mg/1 mL; .2638 mg/1 mL; .064 mg/1 mL | 2020-2 | valid | 2026-10-13 | ||
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine; Sodium Chloride; Sodium Metabisulfite | .032 mg/1 mL; .2638 mg/1 mL; .064 mg/1 mL | 2020-1 | valid | 2026-10-13 | ||
| "Apollo Care, LLC(080452681)" | 71170-510 | 71170-510-25 | Norepinephrine; Sodium Chloride; Sodium Metabisulfite | .032 mg/1 mL; .2638 mg/1 mL; .064 mg/1 mL | 2019-2 | valid | 2026-10-13 |